Single arm, multicenter clinical trial of Actinic Keratosis photodynamic therapy with aminolevulinic acid

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032656

Enrollment

Unknown

Registered

2020-05-05

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic Keratosis

Interventions

Treatment Group:photodynamic therapy with aminolevulinic acid

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Over 18 years of age; 2. The patients who were proved to be AK by pathological examination; 3. The number of AK Lesions >= 1; 4. Sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have serious liver, kidney and heart disease or immune deficiency; 2. Have a history of psychosis, epilepsy, etc.; 3. A woman who is nursing or pregnant; 4. Patients known to have skin photosensitivity, Porphyria, or allergic to porphyrins; 5. Known to have an allergy to iodine; 6. Patients with marked tendency to scar hyperplasia; 7. The researchers considered other participants unsuitable; 8. Unwilling to complete the observation and treatment.

Design outcomes

Primary

Measure	Time frame
Clinical and dermoscopic complete remission rate at 1 month after the last treatment;Clinical and dermoscopic partial response rate at 1 month after the last treatment;	—

Countries

China

Contacts

Public ContactXin Linlin

Department of Dermatology, The First Affiliated Hospital of Shandong First Medical University

xinll158@sina.com+86 13791120870

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026